AptarGroup
ATRAptarGroup is a global leader in the design and manufacturing of drug delivery, consumer product dispensing, and active material science protection technologies.
Earnings
Next report
Date not yet announcedValuation & ratios
Segments
Competitors
By market cap
By revenue growth
Profile
AptarGroup is a global leader in the design and manufacturing of drug delivery, consumer product dispensing, and active material science protection technologies. The company provides highly engineered solutions such as aerosol valves, pumps, and elastomeric components that ensure safe and functional product delivery for the pharmaceutical, beauty, and food industries. Their value proposition centers on proprietary material science and digital health integration to enhance patient outcomes and consumer convenience.
Aptar is a dominant global player in the dispensing and drug delivery market, characterized by high switching costs and deep integration into customer regulatory filings.
FAQ
- What is AptarGroup's market cap?
- AptarGroup (ATR) has a market capitalization of $8.3B and trades on NYSE.
- What is AptarGroup's revenue and profitability?
- AptarGroup generated $4.0B in trailing twelve-month revenue with net income of $267.2M, representing a net margin of 6.7%. Gross margin stands at 35.8%, with free cash flow of $294.7M. The latest reported period is Q3 2026.
- Who are AptarGroup's competitors?
- AptarGroup's key competitors include West Pharmaceutical Services, Silgan Holdings, Trimas Corporation, and others. These companies compete in similar markets and product categories.
- What subsidiaries does AptarGroup have?
- AptarGroup's subsidiaries include Sommaplast, BTY, Goldrain.
- Where is AptarGroup headquartered?
- AptarGroup is headquartered in United States of America and employs approximately 13,800 people. It has been publicly traded since 1993.
